CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Minority/Underserved, Oncology, Pediatric, Rare, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
